with which a sulfate ester and adenosine-3Ј,5Ј-bisphosphate (PAP) are generated as products. The isolation of sulfotransferase cDNAs and genes during the previous decade along with the expression and purification of recombinant enzymes has expanded our knowledge of the diversity and functions of this enzyme family (4) .
Important insights have been gained regarding the structures and chemical mechanisms of sulfotransferases (5) (6) (7) . A highly conserved feature is a histidyl residue in the vicinity of position 108, which may serve as a general base in acceptor substrate proton abstraction. The binding site of PAPS includes conserved lysyl, arginyl, and seryl groups, and acceptor substrate specificity is determined in part by the charge in its binding domain. Many cytosolic sulfotransferases are dimeric, and the dimerization domain has been identified as a relatively simple hydrophobic zipper stabilized on the ends by salt bridges (6) . The simplicity of the dimerization domain may explain the observation of heterodimeric sulfotransferases purified from rat liver (8) .
The role of subunit dimerization in sulfotransferase function is currently under investigation. The tight binding of only 1 eq of PAP per dimeric rat aryl sulfotransferase IV suggests a structural limitation to ligand binding in that enzyme (9) . Also, PAP-dependent cooperativity has been reported for the binding of pentachlorophenol to the bovine SULT1A1 (10) . Nonetheless, there is little evidence to date for a role of subunit interactions during sulfotransferase catalytic turnover.
A variety of steady state kinetic mechanisms have been reported for different sulfotransferases. Partially purified guinea pig liver phenol sulfotransferase was reported to obey a rapid equilibrium random bi bi pattern (11) , whereas partially purified rat brain phenol sulfotransferase displayed a sequential ordered bisubstrate mechanism with PAPS as the leading substrate (12) . A random mechanism was also reported for the more highly purified rat liver aryl (phenol) sulfotransferase IV (13) , although it was noted that an ordered Theorell-Chance mechanism was also consistent with the data. Characterization of the human phenol (SULT1A1) and dopamine (SULT1A3) sulfotransferases revealed ordered bi bi mechanisms with PAPS as the leading substrate (14, 15) . Some caution is warranted as we look back on work performed with partially purified nonrecombinant enzymes; however, all reports provide a consistent picture that PAPS can bind to the enzyme in the absence of a phenol. This is supported by the frequent use of nucleotide agaroses for affinity purification (16, 17) , by the presence of PAP found tightly bound to a recombinant rat enzyme (9) , and by recent crystallization of mouse estrogen sulfotransferase complexes with PAP and PAPS (18) .
Much emphasis has been placed on elucidating substrate specificities for various members of the sulfotransferase family (16) , which often display overlapping reactivities with many acceptor substrates. Quantitative structure activity relationships have revealed clear differences between the human phenol sulfotransferase (SULT1A1) and the dopamine sulfotransferase (SULT1A3) (7, 19) . Equally important, however, is the likely role that biomolecules play in regulating sulfoconjugation reactions. Exogenous inhibitors include polyphenolic compounds (20, 21) , aryl carboxylic acids (22) , aryl aldehydes (23) , and polyhalogenated phenols (13, 24) . Endogenous inhibitors include ATP (14, 15) , pyridoxal phosphate (25) , and CoA (17) . The latter is of interest due to its overt structural overlap with PAP, another potent sulfotransferase inhibitor (26) generated by normal enzymatic turnover. CoA was found to be a competitive inhibitor with respect to PAPS of the bovine phenol sulfotransferase (bSULT1A1) (17) , an enzyme with very similar sequence and substrate specificity compared with the human SULT1A1 enzyme (27) .
As a ubiquitous biomolecule, CoA fulfills several metabolic and regulatory roles. Whereas the mitochondrial CoA pool is probably not relevant for this investigation, cytosolic CoA is a vital component in fatty acid catabolism, lipid biosynthesis, and drug metabolism (28, 29) . The acylation status of this CoA pool is a dynamic parameter that can shift dramatically depending on cellular physiological conditions (28, 30) . This, in turn, could alter its effects on enzymes such as sulfotransferases. Therefore, we have sought to extend our prior work by comparing the inhibition of bSULT1A1 by various acylated CoAs. The complete characterization of the kinetics of this inhibition indicates an unanticipated complex kinetic pattern that required accounting for inhibitor binding to a dimeric enzyme. These results may reveal an aspect of sulfotransferase catalysis not previously uncovered, namely positive subunit interactions.
EXPERIMENTAL PROCEDURES
Reagents-Buffers and salts were of the highest purity available from either Sigma or Fisher. 2-Naphthol and 2-naphthyl sulfate were from Fluka (Milwaukee, WI) and Research Organics (Cleveland, OH), respectively. CoA and acyl-CoAs, PAPS, PAP, pentachlorophenol (PCP), and 7-hydroxycoumarin (7-HC) were from Sigma. CoAs, PAPS, and PAP were dissolved in water, quantified by absorbance (A ϭ 15.4/mM at 260 nm), and stored frozen as 1-200 mM aliquots. PCP and 7-HC were dissolved in ethanol at 1 M and 0.1 M by mass, respectively, and kept at Ϫ20°C in the dark. These reagents were diluted in water to ϳ100 M working stocks immediately before use.
For some experiments, the commercially available PAPS was purified by ion exchange FPLC. Approximately 0.2 mol of PAPS was bound to a Resource Q column equilibrated with 50 mM triethylamine carbonate, pH 7.6, followed by a 15-ml linear gradient to 1 M buffer. The PAPS peak was collected and lyophilized to remove volatile buffer components and then dissolved in water and quantified by absorbance. When directly comparing unpurified to purified PAPS in bSULT1A1-catalyzed reactions, however, we did not observe any significant differences in either rates or steady state kinetic parameters (not shown).
Recombinant bovine phenol sulfotransferase (bSULT1A1) was purified from E. coli DH5␣ harboring the pTrc-PST cDNA expression vector as previously described (10, 27) , except that the final molecular exclusion over AcA34 was replaced by FPLC through Sephacryl S-200 (Amersham Biosciences, Hi-Prep 26/60). Aliquots of enzyme were stored at Ϫ80°C at 1-2 mg/ml in Buffer B (20 mM Tris, 1 mM EDTA, 10% (w/v) sucrose, 5 mM 2-mercaptoethanol, pH 7.4).
Recombinant human dopamine sulfotransferase (SULT1A3) was purified from E. coli DE3 harboring hM-PST-pET-11a, kindly provided by Dr. Michael Coughtrie. The purification method followed was that used for the bovine SULT1A1 enzyme.
Protein concentrations were determined using the Bio-Rad reagent and bovine serum albumin as the relative standard. bSULT1A1 molarity was calculated assuming a molecular mass of 32 kDa (27) , and hSULT1A3 concentration assumed a subunit mass of 34 kDa (31) .
Methods-Measurement of bSULT1A1 activity was performed by observing the decrease in 7-HC fluorescence essentially as described by Leach et al. (17) , in which 50-l reactions initiated in timed sequence were then sequentially stopped after 5-20 min with an equal volume of 0.5 M Tris-Cl, 0.1% SDS, pH 8.5. The assay buffer was 25 mM sodium phosphate, 25 mM sodium succinate, 0.5 mM EDTA, pH 5.5, a previously reported optimum for this enzyme (32) . If the concentrations of fluorescent 7-HC exceeded 1 M, then sufficient Tris/SDS was added to dilute the total 7-HC to 1 M. The fluorescence intensities of the quenched reactions were then measured using a Hoefer DyNA Quant fluorimeter and 50-l capillary cuvettes. The instrument was frequently blanked and calibrated with a sample of 1.0 M 7-HC, which was within the linear instrumental response. Several precautionary measurements were made to ensure assay validity; first, no substrate was ever depleted beyond 20% of its starting value; second, the incubation times and enzyme concentrations fell within linear dependence; third, the inhibition by the CoAs in the assay buffer was time-independent. Concentrations of PAPS and 7-HC were varied as indicated in the figure legends. To accurately measure a decrease in 7-HC fluorescence during the PAPS variations, we found it necessary to hold the acceptor substrate at 0.2 M. This is sub-saturating and has the consequence of reduced rates in comparison to the 7-HC variation experiments (e.g. Fig. 3 versus Fig. 4 ). In contrast, for assays in which 7-HC was varied, the PAPS concentration was held at 10 M. This higher concentration drove greater reaction rates and allowed estimation of the true turnover number (TN) of the reaction.
Human SULT1A3 activity was determined fluorimetrically by the method of Arand (33) , in which the formation of 2-naphthyl sulfate is measured. Incubations of 100 l included 5 mM sodium phosphate, pH 6.8, 5 M PAPS, and 25 M 2-naphthol. CoA and palmitoyl-CoA concentrations in the assays were varied as indicated (Fig. 2) . Emission intensities were measured with an SLM-AMINCO 8000 spectrofluorimeter (285 nm excitation, 335 nm emission), and relative activities were calculated compared with controls in the absence of inhibitors. Care was taken to select incubation times and enzyme concentration that displayed linearity, and all measurements were conducted in triplicate.
Kinetic data (Figs. 3 and 4) were numerically analyzed as follows. Initial rates were divided by bSULT1A1 subunit concentration, thereby directly providing turnover number (TN) values. Because of the apparent complexity of the inhibition patterns, attempts were made to use a sophisticated software package (Enzfitter, Biosoft, Cambridge, UK) to fit the data to several common mechanisms. However, no equation or algorithm provided a satisfactory model of the data as revealed by excessive standard errors or nonrandom residual distribution (not shown). The apparent cooperativity of inhibition by palmitoyl-CoA ( Fig.  1 ) suggested that a model would need to account for subunit-subunit interactions. Therefore, additional binding schemes were considered that included mixed substrate and inhibitor binding to a dimeric enzyme. Derivation of rapid equilibrium equations was by standard approaches (34) , and the simplest scheme that yielded graphical predictions consistent with the data is provided (Fig. 5) .
Experimental data were then fit to the model as follows. Triplicate rates for a set of varied substrate concentrations for a single concentration of inhibitor were entered into a spreadsheet (Cricket Graph) configured to perform the statistical weighting calculations of Wilkinson (35). For visualization, traditional Lineweaver-Burk plots were constructed displaying the average velocities and the weighted fits. The slopes of these fits (K m /TN) were subsequently plotted against palmitoyl-CoA concentration. Fittings of the slope replots according to the slope portions of Equations 3 and 4 (Table I) were conducted manually in an iterative process. Initial selections of the equation parameters K s1 , K s2 , and TN were made based on rate data in the absence of inhibitor. Co-substrate concentrations were known experimental parameters. The IC 50 value (0.24 M) of palmitoyl-CoA inhibition ( Fig. 1 ) was used as initial estimates of K i1 and K i2 , and ␣ was initially set to 1. It was decided to restrain K i2 from decreasing below 0.01 M, the point at which inhibition of bSULT1A1 activity could be detected (Fig. 1) . The parameters for the two sets of data (Figs. 3 and 4) were then varied independently until visual fits of the experimental slope replots were achieved. Refinements of the fits were then made while minimizing the sum of the squared residuals for each replot, and parameters between the two experiments were progressively converged in small increments. After six iterations, no further minimization of summated squared residuals could be achieved, and the final fits and parameters are reported in Figs. 3 and 4 and Table II. Fluorescence emission spectra were measured using an SLM-AMINCO 8000 spectrofluorimeter with an excitation wavelength of 280 nm. Excited tryptophanyl emission energy is apparently transferred to bound 7-HC, which displays an enhanced emission around 400 -420 nm.
2 All spectra were recorded at ambient temperature and were corrected for the small dilutions due to titrant additions. For most experiments, 1.50-ml samples in Buffer B included a magnetic stirrer in the quartz cuvette. Fluorimeter shutters were closed unless spectra were being recorded to minimize UV exposure time. Titrations with stock solutions of CoA, palmitoyl-CoA, or PCP were such that 2-5-l additions of reagent were made, followed by at least 2 min for mixing and equilibration. Preliminary experiments demonstrated that this was sufficient time for binding equilibration to occur (not shown).
Quenching of bSULT1A1 fluorescence with PCP was performed by titrations of 2.0 M solutions of enzyme essentially as previously described (10) . Emission intensities at 338 nm were recorded using 280 nm excitation, and mock titrations were performed to provide empirical dilution correction factors. Inclusion of PAPS, CoA, or palmitoyl-CoA (5 M) reduced the initial emission intensity by at most 5%, which is likely due to an excitation inner filter effect. Therefore, fluorescence values are expressed as percent relative to the sample lacking PCP. Final concentrations of PCP could not exceed about 5 M without introducing a further inner filter artifact (10), thus precluding reliable titration data at greater PCP concentrations (Fig. 8) .
It was also possible to titrate the quenched bSULT1A1⅐PCP complex with palmitoyl-CoA (Fig. 9 ). The 335-nm emission of 0.50 M enzyme in Buffer B was recorded followed by the addition of 3 M PCP, which reduced the fluorescence by 25-30%. Subsequent additions of palmitoyl-CoA caused the return of protein emission to near starting values. Data were corrected for dilution and inner filter effects by performing mock titrations of free enzyme with palmitoyl-CoA or PCP-bound enzyme with 5Ј-AMP, which apparently did not displace PCP from the enzyme. Averaged data from three titrations that varied by less than 5% were modeled with a Hill-type equation (36) by minimizing the sum of squared residuals.
Analytical molecular exclusion column chromatography ( Fig. 10 ) was performed with a Amersham Biosciences FPLC system. The Superdex 200HR column was eluted at 1 ml/min with Buffer B (above) containing 50 mM NaCl. Size standards (bovine serum albumin, chicken ovalbumin, and ␤-lactoglobulin) were from Sigma. Preliminary experiments indicated that 40 M palmitoyl-CoA increased the apparent size of bSULT1A1 in a time-dependent manner over a period of several hours. Therefore, to obtain final equilibrated states, the enzyme (0.6 mg/ml) was incubated with varied concentrations of palmitoyl-CoA for 24 h at ambient temperature before chromatography. Fractions (1 ml) were collected and assayed for bSULT1A1 activity (see above).
RESULTS

Effect of Acyl Chain Length on Sulfotransferase InhibitionPrevious work demonstrated the inhibition of bSULT1A1 by
CoA, and we sought to determine whether various CoA thioesters might exhibit similar or different inhibition in comparison. An overall assessment was therefore made of CoA, acetylCoA, malonyl-CoA, octanoyl-CoA, and palmitoyl-CoA across a broad range of concentrations (Fig. 1) . The IC 50 value for CoA of 33 M was consistent with prior work (17) , and this dose response overlapped those of acetyl-CoA (IC 50 ϭ 39 M) and malonyl-CoA (IC 50 ϭ 40 M). The longer chain-length acylCoAs, however, were clearly more potent bSULT1A1 inhibitors, with palmitoyl-CoA (IC 50 ϭ 0.24 M) being 5 times more effective than octanoyl-CoA (IC 50 ϭ 1.25 M).
To determine whether the effect of acyl-chain length might also apply to other sulfotransferases, we tested the response of human dopamine sulfotransferase (hSULT1A3) to CoA and palmitoyl-CoA (Fig. 2) . This enzyme is highly related to bSULT1A1, although its phenol binding site microenvironment is less hydrophobic due to the existence of Glu-146 (7). Overall, hSULT1A3 is less sensitive to inhibition by CoAs compared with bSULT1A1, although there remains a shift in inhibition between CoA (IC 50 ϭ ϳ1 mM) and palmitoyl-CoA (IC 50 ϭ 100 M). The assays of hSULT1A3 were conducted at a greater pH of 6.8 (see "Methods" under "Experimental Procedures") compared with that optimal for bSULT1A1 of pH ϭ 5.5 ( Fig. 1) , so it was possible that the apparent reduced sensitivity of the human enzyme may have been due to assay conditions. Therefore, the inhibition of bSULT1A1 by palmitoyl-CoA was also re-tested and found to display an IC 50 of 1 M. Thus, bSULT1A1 is 100-fold more sensitive to inhibition by palmitoyl-CoA compared with hSULT1A3 under identical conditions, which reveals that different enzymes in the sulfotransferase superfamily will likely display variable sensitivities to CoA and its thioesters.
Kinetic Characterization of bSULT1A1 Inhibition by Palmitoyl-CoA-Previous work indicated simple competitive inhibition of bSULT1A1 by CoA with respect to PAPS (17) . Because of the dramatic increase in inhibition connected with long acyl chain length (Fig. 1 ) and to determine a true K i value, a detailed investigation into the steady state kinetics with palmitoyl-CoA was undertaken. Initial work employed systematic variation of PAPS and inhibitor, with constant concentration of phenolic substrate (7-HC). Lineweaver-Burk plots of the measured rates are provided for illustration (Fig. 3 ) that indicate a complex or mixed pattern of inhibition. Further measurements with systematic variation of 7-HC acceptor substrate at a fixed concentration of PAPS also revealed complex inhibition (Fig. 4) . Attempts to numerically fit the data using standard equations, such as for competitive, noncompetitive, etc., were not satisfactory (not shown). We observed nonlinear slope replots (Figs. 3  and 4) as part of the graphical analyses, and this behavior suggested a quadratic dependence of inhibition on palmitoylCoA concentration.
Therefore, possible binding schemes were considered that could model the nonlinear slope replots. Previous investigations of the highly similar human SULT1A1 and SULT1A3 steady state kinetic mechanisms suggested ordered bi bi patterns with PAPS as the leading substrate (14, 15) . Importantly, no investigations of sulfotransferase kinetics have to our knowledge taken into account the dimeric quaternary structure that is quite common for this enzyme family. It seems plausible that usual catalytic turnover may, under conditions of subsaturating substrate concentrations, proceed mechanistically via one subunit before the adjoining subunit engages in catalysis. In the presence of an inhibitor, however, we reasoned that a complete binding model should account for both subunits. We also noted, as have others, the relatively slow catalysis by this enzyme family, so rapid equilibrium assumptions in the derivation of mathematical models seemed appropriate.
The simplest model of palmitoyl-CoA binding to bSULT1A1 was to allow sequential reversible binding to the two subunits of the enzyme as an initial dead-end branch from an ordered bi bi scheme. The derived rate equations predicted a constant double reciprocal plot y intercept (not shown), a pattern inconsistent with the experimental results. In contrast, by allowing the binding of inhibitor to an idle subunit during catalysis, both a variable y intercept and nonlinear slope replots were predicted. This scheme is depicted in Fig. 5 , with the binding parameters and equations given in Table I . The results in Figs. 3 and 4 were adequately fit (see "Methods" under "Experimental Procedures") using this model, and the derived values of the dissociation constants are summarized in Table II . There is reasonably good agreement in the values, thus providing some assurance of the adequacy of the binding scheme. It is important to note that binding of the first equivalent of palmitoylCoA has an ϳ100-fold greater dissociation constant compared with the second inhibitor binding step. This result suggests that subunit interactions exist within the dimeric bSULT1A1 that enhance binding of palmitoyl-CoA to the second subunit.
An additional result of the slope replot analysis that suggests subunit interactions is the magnitude of ␣. This term reflects the interaction between the PAPS and palmitoyl-CoA binding equilibria involving the adjoining bSULT1A1 subunits (Fig. 5) . A numerical value of 1 would indicate no subunit interactions; however, the fitted value of 0.65 (Table II) indicates that binding of PAPS reduces the dissociation constant of palmitoyl-CoA on the neighboring subunit. This effect is consistent with the sequential binding of two palmitoyl-CoAs, in which binding of the first augments binding of the second (see previous paragraph). Despite the observation of ␣ being optimized to 0.65, it should be pointed out that the significance of this numerically derived parameter should be cautiously viewed, as variations in ␣ had relatively little impact on the least squares fitting when compared with other parameters.
Disruption of a bSULT1A1⅐PAP⅐7-HC Complex by
CoA and Acyl-CoAs-The binding of 7-HC to bSULT1A1 is accompanied by PAP-dependent enhancement of 7-HC emission at ϳ400 -420 nm, and our previous titrations suggested a binding stoichiometry of 0.5 mol of PAP and 7-HC per mol of enzyme subunits. 2 We were interested in how CoA and acyl-CoAs might Table I and the parameters summarized in  Table II. participate in either the formation or disruption of such a complex. Preliminary experiments indicated that CoA or palmitoyl-CoA could not substitute for PAP in regard to enhancing the binding of 7-HC but rather impaired the formation of the bSULT1A1⅐PAP⅐7-HC ternary complex (not shown). Therefore, preformed complex was titrated with palmitoyl-CoA (Fig. 6) , and the emission of the bound 7-HC at 420 nm was analyzed in detail. With increasing palmitoyl-CoA, the composite emission spectrum displayed a decrease in 420-nm intensity, and the overall appearance approached that of bSULT1A1 and 7-HC in the absence of PAP (Fig. 6, scan 5 versus scan 1) . This is consistent with an equilibrium binding model (Fig. 5 ) in which association of palmitoyl-CoA with a subunit of bSULT1A1 is mutually exclusive of PAP and 7-HC. The ability of palmitoyl-CoA to disrupt the bSULT1A1⅐PAP⅐7-HC complex suggests the reversibility of the initial binding steps.
Based on the inhibition experiments (Fig. 1) , it was postulated that palmitoyl-CoA would disrupt the bSULT1A1⅐PAP⅐7-HC complex at lower concentrations than unesterified CoA. We also sought FIG. 5 . Proposed rapid equilibrium kinetic model describing the catalysis by bSULT1A1 and its inhibition by palmitoyl-CoA. The enzyme is symbolized as EE to reflect its homodimeric structure. Substrates S1 and S2 are PAPS and 7-HC, respectively. Products P1 and P2 are 7-HC sulfate and PAP, respectively, although their order of dissociation is not consequential. I represents palmitoyl-CoA. The dissociation constants are defined in Table I .
TABLE I Definitions of dissociation constants and rapid equilibrium-derived kinetics equations
Grouping by S 1 :
Grouping by S 2 : to compare disruption by CoA nucleotides to that previously observed by PCP, a very tightly binding phenol sulfotransferase inhibitor. Therefore, spectrofluorimetric titrations of bSULT1A1⅐PAP⅐7-HC with CoA and PCP were also performed, and the results are summarized in Fig. 7 . PCP was the most effective titrant in this experiment and was completely disruptive at substoichiometric concentrations. A titration end point of 1 M PCP was obtained (not shown), which is consistent with our previous results that suggest the formation of a bSULT1A1⅐PAP⅐7-HC ternary complex. 2 Palmitoyl-CoA clearly disrupted the complex at lower concentrations in comparison to CoA, which is consistent with the augmented inhibition observed with this long chain acylCoA (Fig. 1 ). As a control for possible confounding denaturation effects, aliquots of disrupted complexes were appropriately diluted in Buffer B (see "Methods" under "Experimental Procedures") containing 100 M PAPS followed by assays of bSULT1A1 activity. Nearly complete enzyme activity was observed (not shown). The titrations data were modeled using a Hill equation (36) , and both CoA and palmitoyl-CoA titrations were best fit with slope factors of 1.3. This equilibrium result provides moderate evidence for the cooperative binding of these nucleotides to bSULT1A1; however, it should be noted that the enzyme is pre-bound with the PAP nucleotide, which may affect the observed CoA binding model.
Palmitoyl-CoA Inhibits PCP-induced Quenching of bSULT1A1
Fluorescence-The kinetic data and rapid equilibrium scheme that modeled those data suggested that binding of palmitoyl-CoA excludes ligand binding to the phenolic site. This notion is supported by the disruption of the bSULT1A1⅐PAP⅐7-HC complex by palmitoyl-CoA and by the inability of the CoA nucleotide to replace PAP in inducing the binding of 7-HC by the enzyme. To further test this model, we titrated bSULT1A1 with PCP, which decreases tryptophanyl emission by ϳ40% upon binding to the enzyme. As shown in Fig. 8 and as previously reported (10), PAPS (5 M) enhanced the affinity of bSULT1A1 for PCP. CoA (5 M) did not have an effect on the PCP titration, suggesting that this inhibitor did not substitute for PAPS in enhancing PCP binding. The concentration of CoA, however, may not have been sufficient to adequately saturate the enzyme based on the dose response for bSULT1A1 inhibition (Fig. 1) .
In contrast to CoA, palmitoyl-CoA (5 M) effectively blocked the PCP-induced quenching of bSULT1A1 (Fig. 8, closed triangles) . Based on the previous kinetics data, this concentration of inhibitor would be sufficient to occupy the majority of available binding sites. Some quenching (ca. 5%) was observed at the greatest PCP concentration, suggesting that the presence of palmitoyl-CoA could be overcome. But it was not possible to use greater PCP concentrations than what is reported due to artifactual inner filter effects. These results are consistent with a model in which the binding of palmitoyl-CoA to bSULT1A1 prevents binding of a phenolic ligand.
The ability of palmitoyl-CoA to prevent PCP-induced quenching of bSULT1A1 fluorescence suggested the converse experiment of titrating PCP-quenched enzyme with the CoA thioester. This experiment (Fig. 9) revealed the predicted return of protein fluorescence intensity as palmitoyl-CoA displaced PCP from the enzyme. The dose responses of these titrations required modeling with a Hill equation and a slope factor (Hill coefficient) of 1.9. This behavior is consistent with kinetic data that also indicated positive bSULT1A1 subunit interactions during the binding of palmitoyl-CoA. The fitted inflection point (ED 50 ) of 0.23 M is sensible because the titrations were conducted with 0.50 M bSULT1A1 subunits.
Palmitoyl-CoA Affects the Hydrodynamic Properties of bSULT1A1-A potential confounding property of long chain acyl-CoA thioesters is detergent activity. Therefore, the possible impact of palmitoyl-CoA on the quaternary structure of bSULT1A1 was investigated by molecular exclusion chromatography (Fig. 10) . Preliminary experiments indicated the elution pattern to be time-dependent (not shown), so samples of enzyme with varied palmitoyl-CoA concentrations were incubated for 24 h before chromatography, a time vastly exceeding the conditions of all other experiments in this report. The enzyme eluted predominately as the homodimer at palmitoylCoA concentrations up to 24 M (Fig. 10, peak c) , at which point a greater M r peak appeared at a predicted tetrameric size (Fig.  10, peak b) . Increased palmitoyl-CoA concentrations enhanced the formation of this apparent tetramer as well as higher relative mass aggregates (Fig. 10, region a) . Excess palmitoylCoA eluted much later than the protein peaks (Fig. 10, peak d) , suggestive of a nonmicellar state. Assays of bSULT1A1 dem- FIG. 6 . Spectrofluorimetric titration of bSULT1A1⅐PAP⅐7-HC with palmitoyl-CoA. The sample initially contained 2.0 M bSULT1A1 (subunits) plus 2.0 M 7-HC, and the emission wavelength was scanned as shown using 280 nm excitation (scan 1). Stock PAP was added to 2.0 M, and the sample was equilibrated for 5 min and then rescanned (trace 2). Subsequent additions of palmitoyl-CoA were made in 0.4 M increments, and scans 3-5 were recorded at 0.8, 2.0, and 4.0 M, respectively. Spectra from other palmitoyl-CoA concentrations are not shown for the sake of clarity. All spectra are corrected for a small dilution effect of less than 2.5%.
FIG. 7.
Comparison of palmitoyl-CoA, CoA, and PCP toward disrupting the bSULT1A1⅐PAP⅐7-HC complex (see Fig. 6 ). Corrected emission intensities at 400 nm were used to calculate the relative changes in fluorescence (see "Methods" under "Experimental Procedures"). Each point is the average of triplicate titrations that varied by less than 5%. These results indicate that although palmitoyl-CoA can affect the apparent quaternary structure of bSULT1A1, the concentrations required to do so are considerably greater than what are required for inhibition (Figs. 1-4) , for disruption of the ternary complex with PAP and 7-HC (Figs. 6 and 7) , or for disruption of the enzyme complex with PCP (Fig. 9 ).
DISCUSSION
The previously published observation of bSULT1A1 inhibition by CoA (17) was anticipated based on the structural similarity to PAPS. What was not predictable was the enhanced inhibition correlated to the presence of a long chain acyl group (Fig. 1) . It is very difficult to adequately propose a docked model of the bSULT1A1-palmitoyl-CoA complex because hydrophobic interactions pose a calculational hurdle, and the acyl and pantetheine groups display considerable structural variation when complexed with other unrelated enzymes (e.g. acylCoA dehydrogenases, citrate synthase, etc.). At this time, we suspect that the hydrophobic acyl chain may fold into the phenol binding site of bSULT1A1. This model is supported by the rapid equilibrium kinetics scheme that describes the inhibition data in which binding of palmitoyl-CoA precludes binding of 7-HC phenolic substrate (Fig. 5) . Furthermore, neither palmitoyl-CoA nor CoA could substitute for PAP in the formation of an enzyme complex with 7-HC but rather disrupted a preformed bSULT1A1⅐PAP⅐7-HC complex (Figs. 6 and 7) . Additionally, palmitoyl-CoA impaired the ability of PCP to induce the quenching of tryptophanyl fluorescence (Figs. 8 and 9 ), which could be due to competition of the acyl group with PCP for binding to the phenol binding site of the enzyme.
Will all sulfotransferases display CoA or acyl-CoA sensitivity? All members of this superfamily utilize PAPS as the sulfuryl donor, which includes the PAP moiety in common with CoA. It therefore seems quite likely that interaction with CoA will be a common feature, although we anticipate variations in the dissociation constants. The human SULT1A3 displayed decreased sensitivities to both CoA and palmitoyl-CoA in comparison to bSULT1A1 (Fig. 2) . The precise basis for this differential sensitivity is not clear in the absence of structural data. It may be that the greater hydrophobicity of the SULT1A1 phenol binding site provides a stronger interaction with the acyl chain of palmitoyl-CoA. The SULT1A3 enzyme phenol binding site includes a charged residue, Glu-146, important in catecholamine binding (7) . This group may destabilize docking of the uncharged acyl chain, resulting in an increased dissociation constant.
A surprising feature of this investigation was the complexity of the kinetics data (Figs. 3-5) . The convex slope replots suggested a quadratic dependence of inhibition on palmitoyl-CoA concentration, and this was adequately modeled by a rapid equilibrium scheme in which binding of the inhibitor to both subunits of the dimeric enzyme was taken into consideration (Fig. 5 , Tables I and II) . Simulation of the results could only be approached as the dissociation constants for palmitoyl-CoA were allowed to diverge so that binding of the first equivalent was less favorable than the second equivalent. Refinements to enhance the numerical fit also suggested that binding of PAPS to one subunit decreases the dissociation constant for palmitoyl-CoA to the adjoining subunit. An alternative model would envision two palmitoyl-CoA binding sites per subunit and, thus, not require cooperativity to explain the experimental results. However, there is no evidence for two PAP binding domains on any sulfotransferase, so this model would be overly speculative. Such positive cooperativity during catalysis has not been, to our knowledge, reported for any member of this enzyme family.
The kinetic behavior observed in this investigation, however, may not be limited to the bovine SULT1A1. In their investigations of the human phenol and dopamine sulfotransferases, Whittemore et al. (14, 15) utilized ATP as an inhibitor to delineate kinetic mechanisms. Although double-reciprocal plots were shown by the authors, slope replots were not reported for this inhibitor. We have scrutinized those results and have observed convex slope replots (not shown). Therefore, it seems likely that other members of this family may exhibit subunit interactions that affect function.
We previously reported that unesterified CoA was a simple competitive inhibitor of bSULT1A1 with respect to PAPS (17) . We now believe this to be an oversimplification, as the slope replot in that report may actually be convex. The curvature was not as great as currently observed with palmitoyl-CoA and, therefore, was overlooked. This comparison in conjunction with the increased sensitivity of bSULT1A1 to palmitoyl-CoA (Fig.  1) suggests that occupation of both the nucleotide and phenol sites may be necessary to fully drive a conformational change that converts the second subunit to a higher affinity state.
The kinetic evidence for cooperative binding of palmitoylCoA is supported by additional equilibrium approaches. Disruption of the bSULT1A1⅐PAP⅐7-HC complex with palmitoylCoA (Fig. 7) was only moderately cooperative (Hill coefficient of 1.3). It should be noted, however, that the enzyme in that experiment was pre-bound with the PAP nucleotide. Titration of the ternary complex with palmitoyl-CoA probably does not begin with a protein conformation identical to the unbound state. In contrast, titration of bSULT1A1⅐PCP with palmitoylCoA (Fig. 9) revealed a high degree of cooperativity (Hill coefficient of 1.9). In this case, the enzyme is nucleotide-free at the beginning of the titration, so it seems reasonable that subunit interactions that facilitate a nucleotide-induced conformational change would be more adequately probed. The tightness of the transition (Fig. 9) is consistent with the kinetic data that indicated a 100-fold difference in the two binding constants for palmitoyl-CoA. It will be interesting to determine whether this can be detected by other biophysical approaches in future experiments.
An important aspect of long chain acyl CoAs is amphilicity and detergent properties, and this can confound investigations if not adequately controlled for. If palmitoyl-CoA acted to denature bSULT1A1, several observations would be anticipated. First, the inhibition would have been dependent on the time of incubation with enzyme. We conducted experiments with varied preincubation of enzyme and palmitoyl-CoA, and no time dependence of inhibition was found (not shown). Second, detergents are typically most effective in the vicinity of their critical micelle concentration, which is 30 -60 M for palmitoyl-CoA (37, 38) . The inhibition of bSULT1A1 by palmitoyl-CoA occurred well below this critical micelle concentration value. Third, samples were tested at the end of titrations with palmitoyl-CoA (Fig. 7) , and full catalytic activity was observed after dilution into assay buffer containing excess PAPS (not shown). Fourth, we have observed that the tryptophanyl emission of bSULT1A1 decreases by 20% upon denaturation with dodecyl sulfate (not shown). Very little if any change in emission is effected by the inclusion of 5 M palmitoyl-CoA with 2 M enzyme (Fig. 8) . Finally, we have used FPLC gel filtration to examine the quaternary structure of bSULT1A1 after incubation with varied concentrations of palmitoyl-CoA (Fig. 10) . Simple dimeric size elution was observed up to about 20 M. Approximately 5% tetrameric size was noted at 24.4 M palmitoylCoA, and roughly 30% conversion to active tetramer and 30% higher M r inactive protein was observed with 50 M palmitoylCoA. Interestingly, there is evidence that palmitoyl-CoA may exist as dimers at concentrations below its critical micelle concentration (37) , so the formation of tetrameric bSULT1A1 (Fig. 10, peak b) may be the result of two protein dimers simultaneously bound to a palmitoyl-CoA dimer. The formation of higher M r aggregates is consistent with palmitoyl-CoA detergent properties, but these concentrations greatly exceed the K i values determined by the kinetic analyses and titration experiments. We conclude that the observations in this report are not due to nonspecific detergent activity of the long chain acyl-CoA.
A complete understanding of enzyme function must take into account substrate kinetics and availability as well as possible inhibitors. In the case of the sulfotransferases, CoA is an important biomolecule that has received little attention as a possible regulatory factor. Although this acyl carrier is perhaps most frequently considered in mitochondrial metabolism, cytosolic CoA is also a vital player in both catabolism and biosynthesis. Structurally, CoA includes a PAP moiety extended by a phosphopantetheine chain. Therefore, there is direct structural overlap between CoA and its thioesters and PAPS, the universal sulfuryl group donor for all sulfotransferases. Given the availability and dynamic composition of the CoA pool, it seems prudent to examine additional members of the sulfotransferase family for sensitivity to CoA and its thioesters. It may be that dietary and other physiological conditions regulate one or more sulfation pathways due to changes in the acylation profile of cytosolic CoA.
